GATILOX 0.3% is indicated for the treatment of bacterial conjunctivitis caused by susceptible
strains of the following organisms:
# Aerobes, Gram-Positive:
– Corynebacterium propinquum.
– Staphylococcus aureus.
– Staphylococcus epidermis.
– Staphylococcus mitis.
– Staphylococcus pneumoniae.
# Aerobes, Gram-Negative:
* Dosage and Administration:
– Day 1 and 2:
Instill one drop every two hours in the affected eye(s) while awake, up to 8 times daily.
– Day 3 through 7:
Instill one drop up to four times daily while awake.
It is contraindicated in patients who are hypersensitive to gatifloxacin, to other quinolones
or to any of the components of this medication.
* Precautions and Warnings:
– Not for injection into the eye.GATILOX 0.3% should not be injected sub-conjunctively, nor
should it introduced directly into the anterior chamber of the eye.
– As with other anti-infective products, prolonged use may result in overgrowth of non-susceptible
organisms, including fungi. If super-infection occurs, discontinue use and institute alternative
– Avoid contaminating the applicator tip with material from the eye, fingers or other source.
– Medication should be discontinued at the first appearance of a skin rash or any sign of
– Patients should be advised not to wear contact lenses if they have signs and symptoms of
– Pregnancy & Lactation: There are no adequate and well-controlled studies in pregnant women
or whether this drug is excreted in human milk, so caution should be exercised when
gatifloxacin is administered to pregnant or nursing women.
* Manufactured by: The Nile Co. for Pharm. & Chem. Ind., for: EPCI (The Egyptian Co. for Pharmaceutical & Chemical Industries).